| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Malformations | 36 | 2023 | 469 | 5.510 |
Why?
|
| Hemangioma | 38 | 2021 | 727 | 4.810 |
Why?
|
| Lymphatic Abnormalities | 14 | 2023 | 134 | 2.340 |
Why?
|
| Veins | 12 | 2018 | 769 | 2.310 |
Why?
|
| Sclerotherapy | 10 | 2023 | 183 | 2.270 |
Why?
|
| Arteriovenous Malformations | 21 | 2023 | 396 | 2.100 |
Why?
|
| Aorta, Abdominal | 4 | 2018 | 627 | 1.400 |
Why?
|
| Nevus | 6 | 2018 | 205 | 1.170 |
Why?
|
| Vascular Neoplasms | 6 | 2020 | 167 | 1.100 |
Why?
|
| Nevus, Blue | 6 | 2024 | 43 | 1.070 |
Why?
|
| Tissue Expansion Devices | 3 | 2018 | 160 | 1.050 |
Why?
|
| Liver Neoplasms | 13 | 2020 | 4363 | 0.980 |
Why?
|
| Lipoma | 7 | 2018 | 296 | 0.960 |
Why?
|
| Musculoskeletal Abnormalities | 5 | 2018 | 101 | 0.930 |
Why?
|
| Thoracic Duct | 3 | 2018 | 71 | 0.890 |
Why?
|
| Thoracoscopy | 4 | 2018 | 186 | 0.890 |
Why?
|
| Sclerosing Solutions | 4 | 2016 | 79 | 0.880 |
Why?
|
| Skin Neoplasms | 21 | 2024 | 5864 | 0.850 |
Why?
|
| Anastomosis, Surgical | 5 | 2018 | 994 | 0.840 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 7 | 2018 | 69 | 0.840 |
Why?
|
| Chylothorax | 3 | 2018 | 83 | 0.780 |
Why?
|
| Portal Vein | 6 | 2013 | 435 | 0.780 |
Why?
|
| Wilms Tumor | 3 | 2017 | 378 | 0.760 |
Why?
|
| Child, Preschool | 90 | 2024 | 42684 | 0.740 |
Why?
|
| Infant | 74 | 2024 | 36541 | 0.730 |
Why?
|
| Blood Vessels | 8 | 2014 | 1110 | 0.700 |
Why?
|
| Hemangioendothelioma | 8 | 2018 | 112 | 0.680 |
Why?
|
| Gastrointestinal Neoplasms | 6 | 2024 | 957 | 0.670 |
Why?
|
| Abnormalities, Multiple | 8 | 2017 | 1423 | 0.660 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2018 | 45 | 0.620 |
Why?
|
| Esophageal Achalasia | 2 | 2018 | 98 | 0.610 |
Why?
|
| Appendectomy | 4 | 2009 | 443 | 0.610 |
Why?
|
| Hemangioma, Capillary | 2 | 2015 | 64 | 0.590 |
Why?
|
| Mesenteric Arteries | 1 | 2018 | 178 | 0.590 |
Why?
|
| Intestinal Volvulus | 2 | 2009 | 82 | 0.580 |
Why?
|
| Lymphedema | 5 | 2021 | 526 | 0.580 |
Why?
|
| Appendicitis | 8 | 2008 | 689 | 0.560 |
Why?
|
| Lymphangioma | 4 | 2012 | 60 | 0.560 |
Why?
|
| Intestinal Perforation | 4 | 2004 | 254 | 0.550 |
Why?
|
| Infant, Newborn | 49 | 2023 | 26394 | 0.540 |
Why?
|
| Child | 97 | 2024 | 80969 | 0.540 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2018 | 746 | 0.520 |
Why?
|
| Registries | 6 | 2018 | 8384 | 0.510 |
Why?
|
| Tissue Expansion | 3 | 2015 | 163 | 0.500 |
Why?
|
| Telangiectasis | 3 | 2017 | 78 | 0.480 |
Why?
|
| Genital Diseases, Male | 2 | 2014 | 84 | 0.470 |
Why?
|
| Arteriovenous Fistula | 4 | 2023 | 320 | 0.460 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2014 | 79 | 0.450 |
Why?
|
| Viscera | 1 | 2014 | 138 | 0.450 |
Why?
|
| Scrotum | 1 | 2014 | 118 | 0.440 |
Why?
|
| Intestinal Atresia | 3 | 2004 | 68 | 0.440 |
Why?
|
| Adolescent | 78 | 2024 | 89247 | 0.440 |
Why?
|
| Capillaries | 5 | 2023 | 756 | 0.430 |
Why?
|
| Penis | 1 | 2014 | 210 | 0.430 |
Why?
|
| Mesentery | 2 | 2015 | 202 | 0.400 |
Why?
|
| Esophageal Atresia | 2 | 2006 | 226 | 0.400 |
Why?
|
| Rectum | 4 | 2011 | 900 | 0.390 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2015 | 1126 | 0.390 |
Why?
|
| Neonatal Screening | 3 | 2017 | 618 | 0.390 |
Why?
|
| Interferon-alpha | 1 | 2016 | 910 | 0.390 |
Why?
|
| Esophagus | 4 | 2018 | 1043 | 0.390 |
Why?
|
| Twins, Conjoined | 2 | 2002 | 41 | 0.370 |
Why?
|
| Genitalia, Male | 1 | 2011 | 87 | 0.370 |
Why?
|
| Polyethylene Glycols | 2 | 2016 | 1197 | 0.370 |
Why?
|
| Genital Neoplasms, Male | 1 | 2011 | 68 | 0.360 |
Why?
|
| Humans | 185 | 2024 | 768887 | 0.360 |
Why?
|
| Syndrome | 8 | 2018 | 3274 | 0.350 |
Why?
|
| Secondary Prevention | 2 | 2016 | 1476 | 0.350 |
Why?
|
| Aortic Coarctation | 1 | 2012 | 278 | 0.350 |
Why?
|
| Retrospective Studies | 53 | 2023 | 81892 | 0.350 |
Why?
|
| Female | 135 | 2024 | 397464 | 0.350 |
Why?
|
| Ultrasonography | 8 | 2017 | 6001 | 0.350 |
Why?
|
| Hamartoma Syndrome, Multiple | 4 | 2014 | 115 | 0.350 |
Why?
|
| Embolization, Therapeutic | 5 | 2018 | 1410 | 0.340 |
Why?
|
| Male | 124 | 2024 | 365249 | 0.340 |
Why?
|
| Mesenteric Veins | 1 | 2010 | 87 | 0.340 |
Why?
|
| Lymphography | 3 | 2018 | 189 | 0.340 |
Why?
|
| Fetus | 5 | 2002 | 1882 | 0.330 |
Why?
|
| Lipomatosis | 1 | 2010 | 112 | 0.320 |
Why?
|
| Arteries | 1 | 2014 | 1126 | 0.320 |
Why?
|
| Phlebography | 4 | 2018 | 326 | 0.310 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 587 | 0.310 |
Why?
|
| Lymphatic Vessels | 4 | 2019 | 356 | 0.310 |
Why?
|
| Venous Thrombosis | 2 | 2010 | 1321 | 0.310 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2006 | 148 | 0.300 |
Why?
|
| Buttocks | 2 | 2008 | 111 | 0.300 |
Why?
|
| Spinal Cord | 3 | 2011 | 1813 | 0.300 |
Why?
|
| Hernia, Abdominal | 1 | 2008 | 58 | 0.290 |
Why?
|
| Treatment Outcome | 34 | 2023 | 65485 | 0.290 |
Why?
|
| Endovascular Procedures | 4 | 2018 | 2218 | 0.290 |
Why?
|
| Sturge-Weber Syndrome | 2 | 2021 | 89 | 0.280 |
Why?
|
| Sutures | 1 | 2009 | 283 | 0.280 |
Why?
|
| Tissue Engineering | 4 | 2006 | 1893 | 0.280 |
Why?
|
| Teratoma | 3 | 2005 | 405 | 0.280 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2005 | 888 | 0.280 |
Why?
|
| Vascular Surgical Procedures | 5 | 2018 | 1515 | 0.270 |
Why?
|
| Sarcoma, Kaposi | 3 | 2016 | 375 | 0.270 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2019 | 331 | 0.270 |
Why?
|
| Pleural Effusion | 2 | 2023 | 345 | 0.270 |
Why?
|
| Vulva | 2 | 2023 | 84 | 0.270 |
Why?
|
| Matrix Metalloproteinases | 2 | 2006 | 393 | 0.270 |
Why?
|
| Fibroblasts | 3 | 2006 | 4178 | 0.270 |
Why?
|
| Hospitals, Pediatric | 4 | 2015 | 1876 | 0.260 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 2005 | 40 | 0.260 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2005 | 50 | 0.250 |
Why?
|
| Fetal Heart | 2 | 2013 | 281 | 0.250 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 2034 | 0.250 |
Why?
|
| Intestinal Obstruction | 2 | 2008 | 433 | 0.250 |
Why?
|
| Catheterization | 2 | 2013 | 1431 | 0.250 |
Why?
|
| Genitalia, Female | 1 | 2006 | 146 | 0.240 |
Why?
|
| Foreign Bodies | 1 | 2009 | 403 | 0.240 |
Why?
|
| Neoplasms, Vascular Tissue | 2 | 2008 | 25 | 0.240 |
Why?
|
| Embolism, Air | 1 | 2005 | 110 | 0.240 |
Why?
|
| Scoliosis | 2 | 2010 | 793 | 0.240 |
Why?
|
| Duodenal Obstruction | 1 | 2004 | 23 | 0.240 |
Why?
|
| Umbilical Veins | 2 | 2017 | 425 | 0.240 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2005 | 244 | 0.230 |
Why?
|
| Spinal Neoplasms | 3 | 2009 | 715 | 0.230 |
Why?
|
| Ultrasonography, Doppler | 4 | 2018 | 463 | 0.230 |
Why?
|
| Lymphatic Diseases | 2 | 2018 | 319 | 0.230 |
Why?
|
| Diagnosis, Differential | 20 | 2020 | 13020 | 0.230 |
Why?
|
| Rabbits | 5 | 2016 | 4774 | 0.230 |
Why?
|
| Sacrococcygeal Region | 1 | 2004 | 53 | 0.230 |
Why?
|
| Jugular Veins | 1 | 2005 | 211 | 0.220 |
Why?
|
| Risk Assessment | 10 | 2017 | 24330 | 0.220 |
Why?
|
| Follow-Up Studies | 22 | 2018 | 39394 | 0.220 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 1769 | 0.220 |
Why?
|
| Iliac Artery | 1 | 2005 | 344 | 0.220 |
Why?
|
| Prenatal Diagnosis | 5 | 2011 | 1274 | 0.220 |
Why?
|
| p120 GTPase Activating Protein | 3 | 2023 | 36 | 0.220 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 4300 | 0.220 |
Why?
|
| Sigmoid Diseases | 1 | 2004 | 59 | 0.220 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2005 | 215 | 0.220 |
Why?
|
| Bronchiectasis | 1 | 2005 | 141 | 0.210 |
Why?
|
| Upper Extremity | 3 | 2019 | 683 | 0.210 |
Why?
|
| Hydrogels | 2 | 2006 | 745 | 0.210 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2004 | 94 | 0.210 |
Why?
|
| Endothelial Cells | 6 | 2022 | 3591 | 0.210 |
Why?
|
| Subcutaneous Tissue | 2 | 2021 | 131 | 0.210 |
Why?
|
| Lung | 3 | 2022 | 10097 | 0.200 |
Why?
|
| Fetofetal Transfusion | 2 | 2002 | 116 | 0.200 |
Why?
|
| Crohn Disease | 4 | 2015 | 2297 | 0.200 |
Why?
|
| Colon | 2 | 2001 | 1804 | 0.200 |
Why?
|
| Granuloma, Pyogenic | 2 | 2020 | 47 | 0.200 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2021 | 36 | 0.190 |
Why?
|
| Hirschsprung Disease | 2 | 2001 | 163 | 0.190 |
Why?
|
| Pulmonary Embolism | 2 | 2018 | 2598 | 0.190 |
Why?
|
| Young Adult | 26 | 2023 | 60110 | 0.190 |
Why?
|
| Digestive System Abnormalities | 1 | 2001 | 49 | 0.190 |
Why?
|
| Gastroschisis | 1 | 2002 | 99 | 0.190 |
Why?
|
| Abdominal Muscles | 1 | 2002 | 172 | 0.190 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2017 | 327 | 0.190 |
Why?
|
| Hernia, Umbilical | 1 | 2002 | 102 | 0.180 |
Why?
|
| Lymphatic System | 4 | 2010 | 251 | 0.180 |
Why?
|
| Osteolysis, Essential | 2 | 2013 | 30 | 0.180 |
Why?
|
| Genital Neoplasms, Female | 1 | 2006 | 538 | 0.180 |
Why?
|
| Bronchi | 1 | 2005 | 850 | 0.180 |
Why?
|
| Lymph Nodes | 4 | 2019 | 3473 | 0.180 |
Why?
|
| Referral and Consultation | 3 | 2012 | 3626 | 0.180 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 4 | 2018 | 906 | 0.170 |
Why?
|
| Artificial Limbs | 3 | 1993 | 121 | 0.170 |
Why?
|
| Intestines | 2 | 2009 | 1911 | 0.170 |
Why?
|
| Anticoagulants | 4 | 2018 | 4850 | 0.170 |
Why?
|
| Lower Extremity | 3 | 2020 | 1217 | 0.160 |
Why?
|
| Receptor, TIE-2 | 2 | 2018 | 182 | 0.160 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 2 | 1992 | 209 | 0.160 |
Why?
|
| Congenital Abnormalities | 3 | 2020 | 703 | 0.160 |
Why?
|
| Fetoscopy | 3 | 1998 | 138 | 0.160 |
Why?
|
| Rectal Diseases | 3 | 2009 | 142 | 0.160 |
Why?
|
| Mutation | 9 | 2020 | 30266 | 0.160 |
Why?
|
| Lung Abscess | 1 | 1999 | 40 | 0.160 |
Why?
|
| Placenta | 2 | 2005 | 1721 | 0.160 |
Why?
|
| Pancreas | 1 | 2006 | 1700 | 0.160 |
Why?
|
| Colectomy | 2 | 2004 | 699 | 0.160 |
Why?
|
| Intraoperative Complications | 2 | 2005 | 1176 | 0.160 |
Why?
|
| Boston | 8 | 2022 | 9375 | 0.160 |
Why?
|
| Spinal Fusion | 2 | 2015 | 1313 | 0.160 |
Why?
|
| Sodium Chloride | 2 | 2011 | 584 | 0.160 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2014 | 1434 | 0.160 |
Why?
|
| Pain | 6 | 2023 | 5100 | 0.160 |
Why?
|
| Diagnostic Errors | 3 | 2011 | 1281 | 0.160 |
Why?
|
| Transplantation, Autologous | 3 | 2018 | 2126 | 0.150 |
Why?
|
| Air | 1 | 1999 | 187 | 0.150 |
Why?
|
| Hamartoma | 2 | 2012 | 236 | 0.150 |
Why?
|
| Myometrium | 1 | 1999 | 174 | 0.150 |
Why?
|
| Defecation | 3 | 2011 | 191 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 1739 | 0.150 |
Why?
|
| Enbucrilate | 1 | 2018 | 30 | 0.150 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2001 | 296 | 0.150 |
Why?
|
| Adult | 51 | 2023 | 223818 | 0.150 |
Why?
|
| Regional Blood Flow | 2 | 2018 | 1502 | 0.150 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2002 | 350 | 0.150 |
Why?
|
| Immunohistochemistry | 7 | 2024 | 11119 | 0.150 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1999 | 133 | 0.150 |
Why?
|
| Amnion | 1 | 1999 | 202 | 0.150 |
Why?
|
| Hypertension, Portal | 2 | 2013 | 230 | 0.150 |
Why?
|
| Suction | 1 | 1999 | 268 | 0.150 |
Why?
|
| Collagen | 1 | 2006 | 2646 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2016 | 2059 | 0.140 |
Why?
|
| Doxycycline | 2 | 2011 | 349 | 0.140 |
Why?
|
| Obstetric Labor, Premature | 1 | 1999 | 266 | 0.140 |
Why?
|
| Genitalia | 1 | 2017 | 113 | 0.140 |
Why?
|
| Gadolinium | 2 | 2014 | 965 | 0.140 |
Why?
|
| Skin Diseases, Vascular | 1 | 2017 | 41 | 0.140 |
Why?
|
| Collateral Circulation | 1 | 2018 | 291 | 0.140 |
Why?
|
| Radiography | 14 | 2017 | 6991 | 0.140 |
Why?
|
| Dilatation | 1 | 2018 | 313 | 0.140 |
Why?
|
| Anesthesia, Local | 1 | 1999 | 279 | 0.140 |
Why?
|
| Databases as Topic | 2 | 2010 | 475 | 0.130 |
Why?
|
| Varicose Veins | 1 | 2018 | 158 | 0.130 |
Why?
|
| Vascular Diseases | 2 | 2020 | 1162 | 0.130 |
Why?
|
| Endothelial Growth Factors | 1 | 1999 | 674 | 0.130 |
Why?
|
| Combined Modality Therapy | 6 | 2015 | 8559 | 0.130 |
Why?
|
| Mediastinal Neoplasms | 1 | 1999 | 403 | 0.130 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2019 | 335 | 0.130 |
Why?
|
| Skin Diseases | 2 | 2020 | 1085 | 0.130 |
Why?
|
| Aortography | 1 | 2018 | 422 | 0.130 |
Why?
|
| Anal Canal | 3 | 2011 | 375 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2020 | 36861 | 0.130 |
Why?
|
| Melena | 1 | 2015 | 32 | 0.130 |
Why?
|
| Rare Diseases | 4 | 2017 | 630 | 0.130 |
Why?
|
| Lymphokines | 1 | 1999 | 927 | 0.130 |
Why?
|
| Skin Abnormalities | 1 | 2016 | 60 | 0.130 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 536 | 0.130 |
Why?
|
| Bupivacaine | 1 | 1999 | 413 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2020 | 555 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2016 | 103 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 524 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 148 | 0.120 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2005 | 1459 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18366 | 0.120 |
Why?
|
| Hemangioma, Cavernous | 1 | 2015 | 107 | 0.120 |
Why?
|
| Antimetabolites | 1 | 2015 | 129 | 0.120 |
Why?
|
| Thalidomide | 1 | 2000 | 886 | 0.120 |
Why?
|
| Soft Tissue Neoplasms | 3 | 2014 | 1166 | 0.120 |
Why?
|
| Neuromuscular Agents | 2 | 2009 | 148 | 0.120 |
Why?
|
| Recurrence | 6 | 2020 | 8512 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 2 | 2005 | 1206 | 0.120 |
Why?
|
| Facial Neoplasms | 1 | 2015 | 126 | 0.120 |
Why?
|
| Incidence | 9 | 2018 | 21545 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 1998 | 943 | 0.110 |
Why?
|
| Receptor, EphB4 | 1 | 2014 | 39 | 0.110 |
Why?
|
| Receptors, FSH | 1 | 2014 | 29 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2013 | 20776 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 2884 | 0.110 |
Why?
|
| Diagnostic Imaging | 4 | 2016 | 3538 | 0.110 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2014 | 47 | 0.110 |
Why?
|
| Dilatation, Pathologic | 2 | 2018 | 527 | 0.110 |
Why?
|
| Ileum | 3 | 2013 | 558 | 0.110 |
Why?
|
| Glomus Tumor | 1 | 2014 | 62 | 0.110 |
Why?
|
| Prosthesis Design | 3 | 2018 | 2126 | 0.110 |
Why?
|
| Popliteal Vein | 1 | 2013 | 43 | 0.110 |
Why?
|
| Tattooing | 1 | 2013 | 57 | 0.110 |
Why?
|
| Pediatrics | 2 | 2018 | 3628 | 0.110 |
Why?
|
| Fascia | 1 | 2014 | 143 | 0.110 |
Why?
|
| Patient Selection | 1 | 2005 | 4265 | 0.110 |
Why?
|
| Bioelectric Energy Sources | 1 | 1993 | 15 | 0.110 |
Why?
|
| Bleomycin | 1 | 2014 | 493 | 0.110 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 4980 | 0.110 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 347 | 0.110 |
Why?
|
| Cohort Studies | 11 | 2018 | 41800 | 0.110 |
Why?
|
| Constipation | 2 | 2011 | 570 | 0.100 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2009 | 238 | 0.100 |
Why?
|
| Kyphosis | 1 | 2015 | 253 | 0.100 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 344 | 0.100 |
Why?
|
| Muscle Neoplasms | 1 | 2014 | 130 | 0.100 |
Why?
|
| Sheep | 5 | 2013 | 1451 | 0.100 |
Why?
|
| Survival Rate | 3 | 2015 | 12873 | 0.100 |
Why?
|
| Receptors, Somatotropin | 1 | 2012 | 58 | 0.100 |
Why?
|
| Enema | 2 | 2011 | 141 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 1999 | 1004 | 0.100 |
Why?
|
| Massachusetts | 3 | 2014 | 8888 | 0.100 |
Why?
|
| Nerve Block | 1 | 1999 | 716 | 0.100 |
Why?
|
| Time Factors | 9 | 2018 | 40266 | 0.100 |
Why?
|
| Hepatic Artery | 1 | 2013 | 232 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2016 | 710 | 0.100 |
Why?
|
| Postoperative Complications | 5 | 2011 | 15889 | 0.100 |
Why?
|
| Delayed-Action Preparations | 1 | 2015 | 969 | 0.090 |
Why?
|
| Length of Stay | 4 | 2018 | 6525 | 0.090 |
Why?
|
| Exsanguination | 1 | 2011 | 36 | 0.090 |
Why?
|
| PUVA Therapy | 1 | 1991 | 101 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 849 | 0.090 |
Why?
|
| Leukapheresis | 1 | 1991 | 150 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 7460 | 0.090 |
Why?
|
| Aortic Diseases | 2 | 2015 | 741 | 0.090 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 489 | 0.090 |
Why?
|
| Databases, Factual | 5 | 2017 | 8095 | 0.090 |
Why?
|
| alpha-Fetoproteins | 1 | 2011 | 229 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 2 | 2011 | 2634 | 0.090 |
Why?
|
| Food Coloring Agents | 1 | 1990 | 7 | 0.090 |
Why?
|
| Down Syndrome | 2 | 2010 | 919 | 0.090 |
Why?
|
| Portal System | 1 | 2010 | 49 | 0.090 |
Why?
|
| Contrast Media | 4 | 2014 | 5334 | 0.090 |
Why?
|
| Lymphangiogenesis | 1 | 2012 | 171 | 0.090 |
Why?
|
| Gastrointestinal Agents | 1 | 2015 | 510 | 0.090 |
Why?
|
| Phlebotomy | 1 | 2011 | 138 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 682 | 0.090 |
Why?
|
| Severity of Illness Index | 8 | 2017 | 15955 | 0.090 |
Why?
|
| Vena Cava, Inferior | 1 | 2013 | 463 | 0.090 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 12093 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2013 | 2589 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 648 | 0.090 |
Why?
|
| Forearm | 1 | 1993 | 428 | 0.090 |
Why?
|
| Saphenous Vein | 1 | 2013 | 519 | 0.090 |
Why?
|
| Melphalan | 1 | 1992 | 421 | 0.090 |
Why?
|
| Constriction, Pathologic | 3 | 2013 | 1104 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 8664 | 0.080 |
Why?
|
| Medical Oncology | 2 | 2018 | 2350 | 0.080 |
Why?
|
| Receptors, Progesterone | 2 | 2012 | 1159 | 0.080 |
Why?
|
| Ligation | 1 | 2010 | 446 | 0.080 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 11262 | 0.080 |
Why?
|
| Extremities | 2 | 2012 | 870 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 1 | 2015 | 714 | 0.080 |
Why?
|
| Risk Factors | 13 | 2018 | 74971 | 0.080 |
Why?
|
| Sampling Studies | 2 | 2011 | 615 | 0.080 |
Why?
|
| Morbidity | 1 | 2014 | 1757 | 0.080 |
Why?
|
| Sex Distribution | 4 | 2017 | 2280 | 0.080 |
Why?
|
| Pulmonary Veins | 2 | 2005 | 758 | 0.080 |
Why?
|
| Pilonidal Sinus | 1 | 2008 | 16 | 0.080 |
Why?
|
| Age Distribution | 4 | 2017 | 2875 | 0.080 |
Why?
|
| Cicatrix | 2 | 2005 | 799 | 0.080 |
Why?
|
| Fecal Incontinence | 1 | 2011 | 246 | 0.080 |
Why?
|
| Leg | 3 | 2013 | 1089 | 0.070 |
Why?
|
| Animals | 18 | 2018 | 169408 | 0.070 |
Why?
|
| Heart Defects, Congenital | 2 | 2002 | 4711 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2019 | 10486 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1111 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2014 | 1019 | 0.070 |
Why?
|
| Hemochromatosis | 1 | 2009 | 176 | 0.070 |
Why?
|
| Fetal Diseases | 2 | 2004 | 916 | 0.070 |
Why?
|
| Colostomy | 1 | 2008 | 106 | 0.070 |
Why?
|
| Duodenal Diseases | 1 | 2008 | 101 | 0.070 |
Why?
|
| Aorta | 1 | 2015 | 2046 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1796 | 0.070 |
Why?
|
| Colon, Sigmoid | 1 | 2008 | 124 | 0.070 |
Why?
|
| Neoplasms, Second Primary | 1 | 2015 | 1060 | 0.070 |
Why?
|
| Dermoid Cyst | 1 | 2008 | 92 | 0.070 |
Why?
|
| Comorbidity | 4 | 2017 | 10591 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4207 | 0.070 |
Why?
|
| Vena Cava Filters | 1 | 2010 | 270 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2017 | 2121 | 0.070 |
Why?
|
| Prednisone | 1 | 1992 | 1567 | 0.070 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2010 | 326 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6546 | 0.070 |
Why?
|
| Middle Aged | 15 | 2018 | 223740 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2005 | 1767 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2000 | 6289 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 6512 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2019 | 3518 | 0.070 |
Why?
|
| Melanoma | 2 | 2016 | 5709 | 0.070 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 2005 | 15 | 0.070 |
Why?
|
| Spinal Dysraphism | 1 | 2008 | 179 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 483 | 0.060 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 58 | 0.060 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 2252 | 0.060 |
Why?
|
| Anemia | 1 | 2015 | 1516 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 1091 | 0.060 |
Why?
|
| Pulmonary Artery | 2 | 2005 | 1945 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2012 | 1120 | 0.060 |
Why?
|
| Eosinophilia | 1 | 1990 | 556 | 0.060 |
Why?
|
| Angiomatosis | 1 | 2005 | 46 | 0.060 |
Why?
|
| Pressure | 2 | 1999 | 1172 | 0.060 |
Why?
|
| Prognosis | 3 | 2017 | 30044 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 752 | 0.060 |
Why?
|
| Inflammation | 1 | 2005 | 10869 | 0.060 |
Why?
|
| Pulse | 1 | 2005 | 218 | 0.060 |
Why?
|
| Disease Progression | 5 | 2012 | 13677 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2063 | 0.060 |
Why?
|
| Bronchography | 1 | 2005 | 74 | 0.060 |
Why?
|
| Pregnancy | 12 | 2012 | 30175 | 0.060 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2006 | 153 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1494 | 0.060 |
Why?
|
| Braces | 1 | 1985 | 139 | 0.060 |
Why?
|
| Esophagoplasty | 1 | 2004 | 48 | 0.060 |
Why?
|
| Dexamethasone | 1 | 1992 | 1965 | 0.060 |
Why?
|
| Endothelium, Lymphatic | 1 | 2024 | 63 | 0.060 |
Why?
|
| Enteral Nutrition | 1 | 1990 | 804 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10778 | 0.060 |
Why?
|
| Gallbladder Emptying | 1 | 2003 | 14 | 0.060 |
Why?
|
| Drowning | 1 | 2003 | 27 | 0.060 |
Why?
|
| Acalculous Cholecystitis | 1 | 2003 | 8 | 0.060 |
Why?
|
| Logistic Models | 6 | 2017 | 13317 | 0.060 |
Why?
|
| Corn Oil | 1 | 2003 | 29 | 0.060 |
Why?
|
| Zebrafish | 2 | 2014 | 3037 | 0.060 |
Why?
|
| Collagen Type III | 1 | 2004 | 92 | 0.060 |
Why?
|
| Spine | 1 | 2011 | 1141 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 2026 | 0.050 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2007 | 452 | 0.050 |
Why?
|
| Models, Animal | 3 | 2016 | 2123 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2011 | 1541 | 0.050 |
Why?
|
| Abdominal Pain | 3 | 2005 | 1070 | 0.050 |
Why?
|
| Tomography, Spiral Computed | 1 | 2005 | 274 | 0.050 |
Why?
|
| Thyroid Nodule | 1 | 2010 | 767 | 0.050 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2005 | 272 | 0.050 |
Why?
|
| Hydrops Fetalis | 1 | 2023 | 113 | 0.050 |
Why?
|
| Injections | 1 | 2006 | 841 | 0.050 |
Why?
|
| Intermittent Claudication | 1 | 2005 | 305 | 0.050 |
Why?
|
| Sports | 1 | 2009 | 703 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1379 | 0.050 |
Why?
|
| Amputees | 1 | 1984 | 100 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 1991 | 1065 | 0.050 |
Why?
|
| Hypertension | 2 | 2013 | 8615 | 0.050 |
Why?
|
| Vulvar Neoplasms | 1 | 2005 | 266 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2004 | 216 | 0.050 |
Why?
|
| Mass Screening | 1 | 2018 | 5455 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 18065 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2004 | 374 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2010 | 1266 | 0.050 |
Why?
|
| Diagnosis-Related Groups | 1 | 2004 | 447 | 0.050 |
Why?
|
| Laparotomy | 2 | 2001 | 459 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 14751 | 0.050 |
Why?
|
| United States | 7 | 2018 | 73180 | 0.050 |
Why?
|
| Primary Health Care | 1 | 1998 | 4748 | 0.050 |
Why?
|
| Disease Transmission, Infectious | 1 | 2007 | 560 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7885 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2004 | 325 | 0.050 |
Why?
|
| Ascites | 1 | 2023 | 338 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2299 | 0.050 |
Why?
|
| Pulmonary Blastoma | 1 | 2001 | 43 | 0.050 |
Why?
|
| Movement Disorders | 1 | 1985 | 464 | 0.050 |
Why?
|
| Congenital Hypothyroidism | 1 | 2001 | 40 | 0.050 |
Why?
|
| DNA | 1 | 2015 | 7214 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2024 | 696 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2002 | 332 | 0.050 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 643 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1866 | 0.050 |
Why?
|
| Cough | 1 | 2005 | 598 | 0.040 |
Why?
|
| Home Infusion Therapy | 1 | 2000 | 18 | 0.040 |
Why?
|
| Lymphangioma, Cystic | 1 | 2000 | 34 | 0.040 |
Why?
|
| Thrombocytopenia | 2 | 2005 | 1181 | 0.040 |
Why?
|
| Technetium | 1 | 2000 | 326 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2019 | 1836 | 0.040 |
Why?
|
| Angiography | 1 | 2005 | 1598 | 0.040 |
Why?
|
| Ischemia | 1 | 2009 | 1900 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2005 | 594 | 0.040 |
Why?
|
| Radiography, Thoracic | 2 | 2014 | 1321 | 0.040 |
Why?
|
| Airway Obstruction | 1 | 2005 | 672 | 0.040 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 197 | 0.040 |
Why?
|
| Adenoma | 1 | 2010 | 2164 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12809 | 0.040 |
Why?
|
| Gait | 1 | 1985 | 822 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2017 | 54950 | 0.040 |
Why?
|
| Child Welfare | 1 | 2003 | 523 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2000 | 365 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2000 | 353 | 0.040 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1999 | 95 | 0.040 |
Why?
|
| Rotation | 1 | 2001 | 517 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 1157 | 0.040 |
Why?
|
| Ethanol | 1 | 2005 | 1332 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2005 | 914 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 2005 | 982 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15471 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2005 | 1758 | 0.040 |
Why?
|
| Face | 1 | 2005 | 1031 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2000 | 295 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2005 | 2730 | 0.040 |
Why?
|
| Laparoscopy | 2 | 2001 | 2055 | 0.040 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2004 | 493 | 0.040 |
Why?
|
| Hypothyroidism | 2 | 2001 | 668 | 0.040 |
Why?
|
| Stem Cells | 1 | 2011 | 3540 | 0.040 |
Why?
|
| Colonic Diseases | 1 | 2000 | 204 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2008 | 1223 | 0.040 |
Why?
|
| Habituation, Psychophysiologic | 1 | 1999 | 148 | 0.040 |
Why?
|
| Fibrosarcoma | 2 | 2002 | 313 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 436 | 0.040 |
Why?
|
| Dissection | 1 | 2020 | 299 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2000 | 351 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2202 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4879 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2000 | 592 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 1794 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2019 | 279 | 0.040 |
Why?
|
| Milk Hypersensitivity | 1 | 1999 | 83 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2018 | 6610 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 1761 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2011 | 2258 | 0.040 |
Why?
|
| Minority Groups | 1 | 2005 | 1216 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 551 | 0.040 |
Why?
|
| Puberty | 2 | 2012 | 501 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 1999 | 517 | 0.040 |
Why?
|
| Somatosensory Cortex | 2 | 1999 | 516 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 6085 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1998 | 139 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1999 | 750 | 0.040 |
Why?
|
| Hypertrophy | 2 | 2012 | 562 | 0.040 |
Why?
|
| Portal Pressure | 1 | 2017 | 62 | 0.030 |
Why?
|
| Acute Disease | 2 | 2005 | 7245 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 1998 | 381 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1999 | 761 | 0.030 |
Why?
|
| Belgium | 1 | 2016 | 119 | 0.030 |
Why?
|
| Bladder Exstrophy | 1 | 1998 | 106 | 0.030 |
Why?
|
| Video Recording | 2 | 1998 | 976 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 2001 | 612 | 0.030 |
Why?
|
| Phantom Limb | 1 | 1998 | 106 | 0.030 |
Why?
|
| General Surgery | 1 | 2008 | 1722 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2007 | 1541 | 0.030 |
Why?
|
| RNA | 1 | 2005 | 2727 | 0.030 |
Why?
|
| Microspheres | 1 | 1999 | 789 | 0.030 |
Why?
|
| Extracorporeal Circulation | 1 | 1996 | 181 | 0.030 |
Why?
|
| Liver | 1 | 2011 | 7579 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 1999 | 6320 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2009 | 9213 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1141 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 2008 | 0.030 |
Why?
|
| Injections, Intramuscular | 2 | 2009 | 556 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 2517 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 1999 | 534 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 392 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 2431 | 0.030 |
Why?
|
| Blood Transfusion | 2 | 2011 | 1309 | 0.030 |
Why?
|
| Necrosis | 1 | 1999 | 1621 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8200 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1999 | 3814 | 0.030 |
Why?
|
| Drainage | 1 | 2000 | 1184 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2000 | 959 | 0.030 |
Why?
|
| Gestational Age | 3 | 2017 | 3610 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 400 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2005 | 2560 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 408 | 0.030 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2014 | 89 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2024 | 2813 | 0.030 |
Why?
|
| Hematology | 1 | 2017 | 243 | 0.030 |
Why?
|
| Head | 2 | 2012 | 927 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4428 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2004 | 2240 | 0.030 |
Why?
|
| Leg Length Inequality | 1 | 2013 | 56 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 1999 | 764 | 0.030 |
Why?
|
| E-Selectin | 1 | 2015 | 578 | 0.030 |
Why?
|
| Physical Examination | 2 | 2010 | 1262 | 0.030 |
Why?
|
| Pneumonia | 1 | 2005 | 2163 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2005 | 2518 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2016 | 1154 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1999 | 1440 | 0.030 |
Why?
|
| Muscle, Smooth | 2 | 2009 | 931 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2018 | 1445 | 0.030 |
Why?
|
| Management Information Systems | 1 | 1992 | 49 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 1998 | 1097 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2014 | 9081 | 0.030 |
Why?
|
| Swine | 2 | 2014 | 5998 | 0.020 |
Why?
|
| Microcomputers | 1 | 1992 | 139 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 11934 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 1625 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2019 | 19023 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3631 | 0.020 |
Why?
|
| Hospitals | 1 | 2005 | 3903 | 0.020 |
Why?
|
| Medicaid | 1 | 2005 | 2843 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 2011 | 80 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2004 | 9682 | 0.020 |
Why?
|
| Ostomy | 1 | 2011 | 33 | 0.020 |
Why?
|
| Age Factors | 3 | 2018 | 18454 | 0.020 |
Why?
|
| Neck | 2 | 2012 | 736 | 0.020 |
Why?
|
| Surgical Stomas | 1 | 2011 | 45 | 0.020 |
Why?
|
| Esthetics | 1 | 1993 | 330 | 0.020 |
Why?
|
| Tartrazine | 1 | 1990 | 1 | 0.020 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2011 | 130 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2000 | 7472 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2000 | 2734 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 768 | 0.020 |
Why?
|
| Dendrimers | 1 | 2010 | 73 | 0.020 |
Why?
|
| Electrolytes | 1 | 2011 | 279 | 0.020 |
Why?
|
| Prone Position | 1 | 2011 | 203 | 0.020 |
Why?
|
| Colitis | 1 | 1999 | 1244 | 0.020 |
Why?
|
| Aged | 4 | 2017 | 171790 | 0.020 |
Why?
|
| Hospital Information Systems | 1 | 1992 | 394 | 0.020 |
Why?
|
| Anesthesia, General | 2 | 2011 | 1189 | 0.020 |
Why?
|
| Bones of Upper Extremity | 1 | 2009 | 6 | 0.020 |
Why?
|
| Colitis, Ulcerative | 2 | 1999 | 1931 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 1998 | 1449 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 1695 | 0.020 |
Why?
|
| Reoperation | 1 | 2020 | 4342 | 0.020 |
Why?
|
| Rats | 2 | 2016 | 23847 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 839 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2005 | 13593 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3625 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 517 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2014 | 3335 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 457 | 0.020 |
Why?
|
| Heparin | 1 | 1996 | 1636 | 0.020 |
Why?
|
| Mosaicism | 1 | 2012 | 481 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2015 | 3102 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 462 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 2736 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 664 | 0.020 |
Why?
|
| Critical Illness | 1 | 2001 | 2754 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 516 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3613 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2041 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2004 | 20244 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6242 | 0.020 |
Why?
|
| Leukocytes | 1 | 1996 | 2034 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 550 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 633 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 559 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 4042 | 0.020 |
Why?
|
| Cell Movement | 1 | 2019 | 5216 | 0.020 |
Why?
|
| Phenotype | 2 | 2020 | 16735 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 498 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9344 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 627 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 1539 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2592 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 2008 | 215 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 2011 | 480 | 0.020 |
Why?
|
| Asia | 1 | 2008 | 629 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2012 | 904 | 0.020 |
Why?
|
| Melanosis | 1 | 2007 | 93 | 0.020 |
Why?
|
| Algorithms | 1 | 2007 | 14199 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 12430 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 2604 | 0.020 |
Why?
|
| Emphysema | 1 | 2008 | 236 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4784 | 0.020 |
Why?
|
| Spina Bifida Occulta | 1 | 1985 | 31 | 0.020 |
Why?
|
| Asthma | 1 | 2005 | 6293 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6901 | 0.020 |
Why?
|
| Wound Healing | 1 | 1997 | 2815 | 0.020 |
Why?
|
| Case Management | 1 | 2007 | 276 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1996 | 2479 | 0.020 |
Why?
|
| Methods | 1 | 1985 | 1066 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 2475 | 0.020 |
Why?
|
| Sex Factors | 2 | 2012 | 10641 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4593 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4941 | 0.010 |
Why?
|
| Skin | 1 | 1998 | 4507 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2008 | 779 | 0.010 |
Why?
|
| Age of Onset | 1 | 2011 | 3346 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 1131 | 0.010 |
Why?
|
| Counseling | 1 | 2012 | 1554 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1985 | 336 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4123 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1993 | 2433 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5890 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 1376 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1627 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2005 | 2173 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 1524 | 0.010 |
Why?
|
| Cardiac Output, High | 1 | 2002 | 6 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1984 | 136 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1998 | 6740 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1991 | 2126 | 0.010 |
Why?
|
| Amputation, Traumatic | 1 | 1984 | 135 | 0.010 |
Why?
|
| Medicine | 1 | 2011 | 947 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3671 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2483 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1705 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2002 | 79 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1998 | 2695 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3446 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2931 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 78 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2016 | 23652 | 0.010 |
Why?
|
| Gallbladder | 1 | 2003 | 308 | 0.010 |
Why?
|
| Observer Variation | 1 | 2008 | 2623 | 0.010 |
Why?
|
| Autopsy | 1 | 2005 | 1013 | 0.010 |
Why?
|
| Bangladesh | 1 | 2003 | 741 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 8055 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 2003 | 409 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2015 | 12469 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2011 | 2701 | 0.010 |
Why?
|
| Fundoplication | 1 | 2001 | 145 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8742 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 945 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 1993 | 3489 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9621 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 2001 | 492 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 1998 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1985 | 2359 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1999 | 180 | 0.010 |
Why?
|
| Canada | 1 | 1984 | 2129 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10276 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 82074 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 3438 | 0.010 |
Why?
|
| Seasons | 1 | 2003 | 1523 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 3629 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12798 | 0.010 |
Why?
|
| Sensation | 1 | 1999 | 337 | 0.010 |
Why?
|
| Patient Care Management | 1 | 2000 | 304 | 0.010 |
Why?
|
| Adolescent Health Services | 1 | 1999 | 220 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2000 | 834 | 0.010 |
Why?
|
| beta-Thromboglobulin | 1 | 1996 | 20 | 0.010 |
Why?
|
| Fibrinopeptide A | 1 | 1996 | 43 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 1996 | 143 | 0.010 |
Why?
|
| Complement C3a | 1 | 1996 | 66 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2231 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 1996 | 125 | 0.010 |
Why?
|
| Software | 2 | 1992 | 4480 | 0.010 |
Why?
|
| Milk | 1 | 1999 | 440 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 1996 | 132 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2167 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2001 | 610 | 0.010 |
Why?
|
| Leukocyte Elastase | 1 | 1996 | 114 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2011 | 8541 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2007 | 3580 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14795 | 0.010 |
Why?
|
| Cost Savings | 1 | 2000 | 915 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4032 | 0.010 |
Why?
|
| Complement Activation | 1 | 1996 | 447 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 2957 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1999 | 866 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1999 | 1004 | 0.010 |
Why?
|
| Shoulder | 1 | 1995 | 300 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2005 | 1946 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1996 | 769 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 1999 | 1136 | 0.010 |
Why?
|
| Thalamus | 1 | 1999 | 1050 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1999 | 1428 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1996 | 1609 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 27476 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2008 | 4859 | 0.010 |
Why?
|
| Cerebellum | 1 | 1999 | 1522 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1998 | 1162 | 0.010 |
Why?
|
| Motor Cortex | 1 | 1999 | 1014 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1728 | 0.010 |
Why?
|
| Amygdala | 1 | 1999 | 1382 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1996 | 1161 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2000 | 2527 | 0.000 |
Why?
|
| Pain Measurement | 1 | 1999 | 3585 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2003 | 9384 | 0.000 |
Why?
|
| Emergency Medical Services | 1 | 1999 | 1947 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5544 | 0.000 |
Why?
|
| Biopsy | 1 | 1999 | 6805 | 0.000 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1992 | 1196 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 21187 | 0.000 |
Why?
|
| Forecasting | 1 | 1992 | 2946 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1999 | 5834 | 0.000 |
Why?
|